Spatial transcriptomics uncovers TAC-OGEs heterogeneity and FN1/MMP9 signature in ameloblastoma
Authors:
Open Access
- 30 April 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1770116
Abstract
Objective: This study aims to explore how the tumour microenvironment influences the aggressiveness, malignancy, and recurrence of ameloblastoma. By employing a spatial omics approach, we will examine the characteristics of the invasive front of ameloblastoma. Methods: We systematically characterised the cellular heterogeneity of ameloblastoma using spatial transcriptomic sequencing combined with integrated omics analysis of clinical tumour specimens. Additionally, we independently validated the spatial expression patterns and levels of FN1 and MMP9 in ameloblastoma through immunohistochemistry in an independent case series of 15 specimens, further supported by single-cell resolution multiplex immunofluorescence. Results: Spatial transcriptomic sequencing delineated the ameloblastoma tumour ecosystem into seven primary cell clusters: epithelial tumour cells, fibroblasts, myeloid cells, endothelial cells, T cells, B cells, and Tumour-associated cells with osteoclast-like gene expression (TAC-OGEs). Significantly, cell clusters located at the tumour’s invasive front demonstrated notably increased expression of FN1 and MMP9. A more detailed analysis within the TAC-OGE compartment identified seven phenotypically distinct subclusters. Interestingly, their differentiation states formed a spatial gradient, extending from the tumour core to the periphery. This spatial expression pattern of FN1 and MMP9 was confirmed through immunohistochemical staining at the tumour-stroma interface. Conclusion: Our findings collectively reveal the cellular heterogeneity of ameloblastoma and highlight tumour-margin-associated TAC-OGEs as potential spatially associated components of local invasion. These results suggest that targeting TAC-OGE-associated processes may represent a potential therapeutic strategy in the management of ameloblastoma.Keywords
This publication has 35 references indexed in Scilit:
- CLIC4 Function in the Epithelial-Mesenchymal Transition of Epithelial Odontogenic LesionsHead and Neck Pathology, 2024
- Tumor microenvironment of ameloblastoma with a focus on osteoclastogenesis, cell migration, and malignant transformationJournal of Oral Biosciences, 2024
- Identification of ferroptosis-related proteins in ameloblastoma based on proteomics analysisJournal of Cancer Research and Clinical Oncology, 2023
- Immunohistochemical expression of E-cadherin, N-cadherin and Snail/slug in ameloblastomaJournal of Stomatology Oral and Maxillofacial Surgery, 2022
- Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone TumoursHead and Neck Pathology, 2022
- Diagnosis and Management of Multiple MyelomaJAMA, 2022
- Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destructionPhytomedicine, 2022
- Bone health in cancer: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2020
- Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair2017
- Prostate-specific antigen induces apoptosis of osteoclast precursors: Potential Role in osteoblastic bone metastases of prostate cancerThe Prostate, 2006